SOUTH PLAINFIELD, N.J., Nov. 18, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the launch of a no-cost testing program for aromatic L-amino acid decarboxylase (AADC) ...
An ultra-rare enzyme deficiency that keeps infants from achieving proper muscle function among other developmental delays now has its first FDA-approved treatment. The new product, a gene therapy ...
WARREN, N.J., Nov. 13, 2024 /PRNewswire/ -- PTC Therapeutics (PTCT), Inc. announced today the U.S. Food and Drug Administration (FDA) accelerated approval of its gene therapy for the treatment of AADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback